Projekt · Dnr 2021-01778 · Källa: Vinnova

Innovative Strategy for Targeted Delivery of Precision Medicine Drugs (INSPIRE)

Koordinator
Uppsala Therapeutics AB
Projekttid
2021-05-01 till 2023-04-30 (avslutat)
Beviljat bidrag
1 918 560 SEK
Diarienummer
2021-01778

Beskrivning

The aim of the project was to synthesize chemically modified oligonucleotides that are sensitive to stimuli like alkaline phosphatase and esterase. We have developed esterase-sensitive drug-siRNA conjugates and alkaline-sensitive chemically modified siRNA and DisiRNA. All our siRNAs are functional in invitro condition tested and the results will be published in due course.

Öppna hos Vinnova

Hittar Vinnova inte sidan? Sök på diarienumret hos Vinnova.

Liknande

  1. E!114537, PROPEL, Uppsala Universitet

    Uppsala universitet · 2020-10-01 · 1 949 953 SEK · Projekt

    To determine the invitro therapeutic efficacy of chemically (guanidinium) modified siRNA we have designed a post-synthetic chemically (guanidinium) modified oligonucleotide through hydrazone linkage. As a proof of concept, we introduced our aldehyde modification on STAT3 and CHMP targeting siRNAs wi…

  2. Laboratory and Research Reagents and Kits

    Kungliga Tekniska högskolan · 2025-11-04 · sista anbudsdag 2025-12-08 · 100 000 000 SEK · Upphandling

    A wide range of products with varying characteristics is required to ensure accurate results in research experiments within Biology such as Cell biology, Molecular Biology, Microbiology, Biochemistry and Neuroscience, and Chemistry such as Analytical chemistry, organic/inorganic chemistry (synthes…

  3. Laboratory and Research Reagents and Kits

    Kungliga Tekniska högskolan · 2026-02-23 · 1 000 000 000 SEK · Tilldelning

    A wide range of products with varying characteristics is required to ensure accurate results in research experiments within Biology such as Cell biology, Molecular Biology, Microbiology, Biochemistry and Neuroscience, and Chemistry such as Analytical chemistry, organic/inorganic chemistry (synthes…

  4. E!11481, E-OxidoCurin, HDXperts AB

    HDxperts AB · 2017-10-01 · 4 888 259 SEK · Projekt

    All the goals of the project were fulfilled. 1) A new water-soluble lead compound LCTA2940 was synthesized. 2) The TrxR1 target was validated, and the mechanism of interaction and ROS dependent action was elucidated. 3) Using proteomics, we identified additional targets. 4) In vivo LCTA2940 effectiv…

  5. Enrichment reagents for NGS

    Kungliga Tekniska högskolan · 2026-04-21 · sista anbudsdag 2026-05-25 · 20 000 000 SEK · Upphandling

    Royal Institute of Technology (KTH ) hereby invites suppliers to submit a tender for design of custom panels and deliver of custom panels for targeted sequencing using NGS (Next Generation Sequencing) on a small scale.